Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Safer Agents for Chemical Reductions

By Biotechdaily staff writers
Posted on 18 Jul 2005
A new range of safer, air-stable reducing agents has been developed for use in chemical synthesis.

The new lithium aminoborohydride (LB) reagents were developed by Prof. More...
Bakthan Singaram at the University of California, Santa Cruz (USA\) and have been licensed to Aldrich, a division of Sigma-Aldrich Corp. (St. Louis, MO, USA). Aldrich has used its strength in boron chemistry to develop and commercialize Prof. Singaram's technology. The highly reactive reagents, used for reduction and amination, offer a safer alternative to the widely used lithium aluminum hydride (LaA1H4, or LAH).

"LAB reagents extend the toolbox for C-N bond formation while offering the advantages of safety, ease of handling, and simple work-up procedures in typical reductions,” explained Chris Hewitt, director of business development for chemistry at Sigma-Aldrich. "These properties will enable scientists who may be reluctant to use LAH and other reagents to routinely perform chemical reductions in high yields and without difficulty.”

"In addition to showing comparable reactivity to LAH, LAB reagents are safe and do not liberate hydrogen when quenched with water,” added Prof. Singaram. "In undergraduate teaching laboratories, transformations that would seldom be attempted to avoid the use of LAH or borane, such as the reduction of tertiary amides or esters, may become routine experiments with the use of LAB.”

Sigma-Aldrich notes that more than one million scientists use its products. The company operates in 35 countries around the world.





Related Links:
Sigma-Aldrich
Univ. California, SC

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.